NanoInk, Inc., one of the world’s leading nanotechnology enterprises, announced today the launch of its NanoBioDiscovery Division. The new division will utilize Dip Pen Nanolithography(R) nanofabrication techniques, in combination with proprietary detection systems, to produce uniquely sensitive assays for protein discovery and identification. Femtofluidics handling of samples and reagents with these systems will help provide […]

Bender MedSystems announces the availability of FlowCytomix, bead-based immunoassays for Multiple Analyte Detection, for the quantitative detection of analytes related to Th17 research. Human IL-17A, IL-22, IL-23, IL-6, TNF-alpha, and many more can be quantified simultaneously in cell culture supernatants, serum and plasma (IL-17A: serum and cell culture supernatants only). Following the convenient protocol, only […]

DNA2.0 opens DNA2.0 Ltd. in the United Kingdom and hires Michael Dyson to run European operations. Menlo Park, CA (PRWEB) December 10, 2008 — DNA2.0, the leading gene synthesis and protein engineering company, today announced the expansion of the company’s European operations with the creation of the United Kingdom-based DNA2.0 Ltd. Michael Dyson, PhD, has […]

Promega Corporation in conjunction with Kazusa DNA Research Institute (KDRI) in Chiba Prefecture, Japan will soon offer vectors encoding Promega HaloTag™ with genetic content from KDRI’s catalog. The KDRI content derives from large, typically difficult to clone human genes. In addition, there will be a comprehensive catalog of human transcription factors commonly used in research […]

Produced under class 10,000 clean room conditions from ultra-pure grade polypropylene, BactiGrowth plates from Porvair Sciences Ltd. contain no contaminants that may leach out and affect high yield growth of bacteria, yeast, mammalian or insect cell lines. Every batch of BactiGrowth plates is rigorously tested to validate their contamination-free status ensuring reproducibility and maintaining customer […]

MARCY L’ETOILE, France, Dec. 8 — bioMerieux, a world leader in the field of in vitro diagnostics has acquired PML Microbiologicals Inc., a leading provider of culture media and microbiological products in North America for both clinical and industrial applications. This privately held American in vitro diagnostics company has manufacturing and marketing teams based in […]

TUCSON, Ariz.–HTG, Inc., provider of the quantitative Nuclease Protection Assay (qNPA™) system and service partner for the life sciences industry, today announced a collaboration agreement with researchers at Harvard Catalyst Laboratory for Innovative Translational Technologies (HC-LITT) at Harvard Medical School. Under the terms of the agreement, HTG and HC-LITT will collaborate to generate a novel […]

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it has acquired the intellectual property (IP) assets of Nucleonics, Inc., a privately held biotechnology company. The Nucleonics IP estate includes over 100 active patent filings, including 16 that have granted worldwide and 6 that have been granted in the U.S., Europe, […]

Millipore Corporation (NYSE:MIL) today announced it has entered into a worldwide, non-exclusive license agreement with Astellas Pharma, Inc. (“Astellas”) to use Millipore’s UCOE™ (Ubiquitous Chromatin Opening Element) technology in its research programs. The license will enable Astellas to more efficiently produce its drug targets, such as antibodies in mammalian cells, by generating higher protein yields. […]